Pipeline
The selection of novel molecular targets is based on well-defined signaling pathways in disease biology and clinical research;
Novel compound design with distinct structural scaffolds enables our strong IP positioning;
High efficiency and productivity in advancing proprietary assets demonstrate our company’s global competitiveness
